818 related articles for article (PubMed ID: 27225182)
1. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.
Kumar DK; Choi SH; Washicosky KJ; Eimer WA; Tucker S; Ghofrani J; Lefkowitz A; McColl G; Goldstein LE; Tanzi RE; Moir RD
Sci Transl Med; 2016 May; 8(340):340ra72. PubMed ID: 27225182
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.
Eimer WA; Vijaya Kumar DK; Navalpur Shanmugam NK; Rodriguez AS; Mitchell T; Washicosky KJ; György B; Breakefield XO; Tanzi RE; Moir RD
Neuron; 2018 Jul; 99(1):56-63.e3. PubMed ID: 30001512
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
Wan L; Nie G; Zhang J; Luo Y; Zhang P; Zhang Z; Zhao B
Free Radic Biol Med; 2011 Jan; 50(1):122-9. PubMed ID: 21034809
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
Wang X; Yi K; Zhao Y
Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
[TBL] [Abstract][Full Text] [Related]
6. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.
Gosztyla ML; Brothers HM; Robinson SR
J Alzheimers Dis; 2018; 62(4):1495-1506. PubMed ID: 29504537
[TBL] [Abstract][Full Text] [Related]
10. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
[TBL] [Abstract][Full Text] [Related]
12. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
Godini R; Pocock R; Fallahi H
PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
[TBL] [Abstract][Full Text] [Related]
13. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
[TBL] [Abstract][Full Text] [Related]
14. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
15. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
16. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
17. Metabolic stress is a primary pathogenic event in transgenic
Teo E; Ravi S; Barardo D; Kim HS; Fong S; Cazenave-Gassiot A; Tan TY; Ching J; Kovalik JP; Wenk MR; Gunawan R; Moore PK; Halliwell B; Tolwinski N; Gruber J
Elife; 2019 Oct; 8():. PubMed ID: 31610847
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
20. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]